GSC The List

Post Reply
Forum Home > A > ALLERGIES AND CANNABIS*+

[email protected]
Site Owner
Posts: 1174

Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity (full – 2010) http://www.nature.com/aps/journal/v31/n12/full/aps2010155a.html

Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB(1)/CB(2) receptors (abst – 2010) http://www.unboundmedicine.com/medline/ebm/record/21056512/abstract/Beneficial_effects_of_cannabinoids__CB__in_a_murine_model_of_allergen_induced_airway_inflammation:_Role_of_CB_1_/CB_2__receptors_

Protective role of palmitoylethanolamide in contact allergic dermatitis (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/19909294

The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20150748

Effects of palmitoylethanolamide on the cutaneous allergic inflammatory response in Ascaris hypersensitive Beagle dogs. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21601500

Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Up regulation of Serum IgE Levels in Immunized Mice (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419805/

Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitis (full – 2012) http://www.biomedcentral.com/1746-6148/8/230

Endocannabinoids limit excessive mast cell maturation and activation in human skin (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22226549

Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22697514?dopt=Abstract

The cannabinoid receptor-2 is involved in allergic inflammation (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22525379

Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation (full – 2013) http://www.jimmunol.org/content/190/10/4929.long

Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23453134

Effect of endocannabinoids on IgE-mediated allergic response in RBL-2H3 cells (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23731947

Cannabinoid CB2 receptors as novel target for inhibiting house dust mite induced allergic airway inflammation (abst – 2013) http://www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/120.12?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf

Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23889474

The expression of cannabinoid receptor 1 is significantly increased in atopic patients (full – 2014) http://www.jacionline.org/article/S0091-6749%2813%2902936-9/fulltext

March 11, 2015 at 9:11 PM Flag Quote & Reply

This topic is closed, no additional posts are allowed.